Related Experiment Video
Updated: Aug 28, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
[Chronic hepatitis C and HIV. Current therapeutic options]
Abstract:
A co-infection with HCV and HIV promotes the development of liver cirrhosis. The avoidance of this hepatic death-trap is therefore the primary aim of treatment for hepatitis C. Up until the end of the year 2000, the standard therapy for hepatitis C in HIV-negative patients was the combination of interferon alpha and ribaverin. The pegylated interferons that became available last year appear to offer advantages. For patients co-infected with HIV, however, no studies have so far been carried out. Combination "partners" of interferon capable of replacing or supplementing ribaveron are presently in the clinical development stage.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Hepatitis
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Viral Hepatitis I: Introduction

